Patent foramen ovale: What cardiologists and neurologists need to know
- PMID: 31025520
- DOI: 10.1002/ccd.28293
Patent foramen ovale: What cardiologists and neurologists need to know
Abstract
In the presence of a patent foramen ovale (PFO), a transient ischemic attack is indistinguishable from a complex migraine. Both have transient neurologic deficits with a normal MRI. The size of a PFO by echo should not be a criterion for closure. A stroke or peripheral embolus associated with a PFO is the indication for closure. Informed consent for PFO closure should include the warning that about 1 in 500 cases require device removal through open-heart surgery.
© 2019 Wiley Periodicals, Inc.
Comment on
-
Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient-years of follow up.Catheter Cardiovasc Interv. 2019 May 1;93(6):1080-1084. doi: 10.1002/ccd.27984. Epub 2018 Nov 20. Catheter Cardiovasc Interv. 2019. PMID: 30461175